Next Article in Journal
Melatonin as an Efficient and Eco-Friendly Tool to Increase Yield and to Maintain Quality Attributes during Lemon Storage
Previous Article in Journal
Chondroitin Sulfate for Cartilage Regeneration, Administered Topically Using a Nanostructured Formulation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586

1
Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway
2
Department of Clinical Cancer Research, Oslo University Hospital, 0424 Oslo, Norway
3
Faculty of Health Sciences, Oslo Metropolitan University, 0130 Oslo, Norway
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(18), 10024; https://doi.org/10.3390/ijms251810024
Submission received: 5 September 2024 / Accepted: 5 September 2024 / Published: 18 September 2024
In the original publication [1], there was a mistake in Figure 6A. When the IVIS images of two mice in JK10 group day 17 were cropped from the original larger image to fit with the layout, a mistake occurred so that one JK10 mouse was replaced with a JK11 mouse. The analyzed data were correct; as were Figure 6B–D. Only the image of the individual mouse was wrong. The corrected Figure 6 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Jin, Y.; Dunn, C.; Persiconi, I.; Sike, A.; Skorstad, G.; Beck, C.; Kyte, J.A. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586. [Google Scholar] [CrossRef] [PubMed]
Figure 6. CD28 and 4-1BB CAR T cells inhibit tumor growth in vivo. (A) Bioluminescence images of individual mice at multiple time points in a subcutaneous tumor model. NSG mice were engrafted subcutaneously on both hind legs with 2 × 106 luciferase expressing 22Rv1 prostate cancer cells. On days 10 and 17, the mice were treated with 1 × 107 non-transduced (NT) T cells (Ntumor = 6) or CD28 CAR T cells (Ntumor = 12) and 4-1BB CAR T cells (Ntumor = 12) by intravenous injection. Bioluminescence signals of individual mice were measured at indicated time points (days after tumor engraftment). (B) Tumor growth is measured once a week by bioluminescence IVIS imaging. The data are presented as the mean ± SEM of tumors in each group. (C) Bioluminescence signals (mean ± SEM) 38 days after tumor engraftment. Statistical analyses in (B,C) were performed with the Mann–Whitney U test. NS (not significant), ** p < 0.001. (D) The body weight of the mice was measured once per week after the first treatment with T cells on day 10. Error bars indicate SD.
Figure 6. CD28 and 4-1BB CAR T cells inhibit tumor growth in vivo. (A) Bioluminescence images of individual mice at multiple time points in a subcutaneous tumor model. NSG mice were engrafted subcutaneously on both hind legs with 2 × 106 luciferase expressing 22Rv1 prostate cancer cells. On days 10 and 17, the mice were treated with 1 × 107 non-transduced (NT) T cells (Ntumor = 6) or CD28 CAR T cells (Ntumor = 12) and 4-1BB CAR T cells (Ntumor = 12) by intravenous injection. Bioluminescence signals of individual mice were measured at indicated time points (days after tumor engraftment). (B) Tumor growth is measured once a week by bioluminescence IVIS imaging. The data are presented as the mean ± SEM of tumors in each group. (C) Bioluminescence signals (mean ± SEM) 38 days after tumor engraftment. Statistical analyses in (B,C) were performed with the Mann–Whitney U test. NS (not significant), ** p < 0.001. (D) The body weight of the mice was measured once per week after the first treatment with T cells on day 10. Error bars indicate SD.
Ijms 25 10024 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jin, Y.; Dunn, C.; Persiconi, I.; Sike, A.; Skorstad, G.; Beck, C.; Kyte, J.A. Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586. Int. J. Mol. Sci. 2024, 25, 10024. https://doi.org/10.3390/ijms251810024

AMA Style

Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA. Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586. International Journal of Molecular Sciences. 2024; 25(18):10024. https://doi.org/10.3390/ijms251810024

Chicago/Turabian Style

Jin, Yixin, Claire Dunn, Irene Persiconi, Adam Sike, Gjertrud Skorstad, Carole Beck, and Jon Amund Kyte. 2024. "Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586" International Journal of Molecular Sciences 25, no. 18: 10024. https://doi.org/10.3390/ijms251810024

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop